Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedTech Forum 2023: Europe’s Regulatory Maze Must Be Simplified, But How?

Executive Summary

Navigating Europe’s increasingly complex maze of regulations was the topic du jour at this year’s MedTech Forum conference. Despite growing concerns that the EU is losing its historic attractiveness for companies, a spirit of resilience characterized the busy three-day meeting.

You may also be interested in...



Is The Implementation Of The EU Medtech Regulatory Structure Entering A New Phase?

Three weeks have gone by now since the European Commission published a “latest update” on the medical device sector pages of its website. What does this mean for the sector?

EU AI Act Amendments Get Green Light From Parliament Committees In Latest Vote

The European Commission’s hotly debated AI Act proposal is a step closer to becoming law after 13 amendments were voted in by members of the European Parliament. The landmark legislation is set to have an enormous impact on all AI products, including many medical devices.

Bisazza To Take The Helm As CEO of MedTech Europe From Early 2023

There is to be a smooth transition at the top of the EU’s largest medtech industry association as news emerges that Oliver Bisazza will step into the CEO position from early January.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel